Target
Mu-type opioid receptor
Ligand
BDBM464444
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
33.0±n/a nM
Citation
 Kuehnert, SKoenigs, RMJakob, FKless, AWegert, ARatcliffe, PJostock, RKoch, TLinz, KSchroeder, W 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10793528 Publication Date 10/6/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM464444
Synonyms:
US10793528, Example SC_5014
Type:
Small organic molecule
Emp. Form.:
C29H44N4O4
Mol. Mass.:
512.6841
SMILES:
CN(C)[C@]1(CC[C@]2(CN(CCC(=O)N3CC[C@H](O)[C@@H](O)C3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.24,3.2,18.18,wD:16.16,(3.99,5.27,;5.08,4.18,;6.57,4.58,;4.68,2.69,;4.68,1.15,;3.35,.38,;2.02,1.15,;.61,1.78,;-.42,.64,;-1.95,.8,;-2.86,-.45,;-4.39,-.29,;-5.02,1.12,;-5.3,-1.53,;-4.67,-2.94,;-5.57,-4.19,;-7.11,-4.03,;-8.01,-5.27,;-7.73,-2.62,;-9.26,-2.46,;-6.83,-1.37,;.35,-.7,;-.28,-2.1,;1.85,-.38,;3,-1.41,;2.68,-2.91,;1.39,-3.75,;2.23,-5.04,;3.52,-4.21,;2.02,2.69,;3.35,3.46,;6.21,2.49,;6.8,1.07,;8.33,.87,;9.26,2.09,;8.67,3.51,;7.15,3.72,)|
Structure:
Search PDB for entries with ligand similarity: